Astrid Clarke

1.6k total citations
27 papers, 1000 citations indexed

About

Astrid Clarke is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Astrid Clarke has authored 27 papers receiving a total of 1000 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Oncology. Recurrent topics in Astrid Clarke's work include Chronic Lymphocytic Leukemia Research (7 papers), DNA Repair Mechanisms (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Astrid Clarke is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), DNA Repair Mechanisms (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). Astrid Clarke collaborates with scholars based in United States, France and Japan. Astrid Clarke's co-authors include Lorraine Pillus, Arthur M. Mercurio, Sandra Jacobson, Margaret Lotz, Celia Chao, G Steele, Charles W. Andrews, Elizabeth Breen, Glenn Steele and Terry L. Orr‐Weaver and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Astrid Clarke

25 papers receiving 985 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Astrid Clarke United States 11 715 234 171 141 124 27 1000
Tove Irene Klokk Norway 18 460 0.6× 203 0.9× 137 0.8× 135 1.0× 54 0.4× 26 940
Sylvia Braselmann United States 9 557 0.8× 394 1.7× 138 0.8× 65 0.5× 59 0.5× 15 1.0k
Vinay Bhaskar United States 9 458 0.6× 135 0.6× 211 1.2× 93 0.7× 169 1.4× 14 816
Rajiv D. Kalraiya India 18 530 0.7× 330 1.4× 82 0.5× 177 1.3× 42 0.3× 31 781
Keisuke Aoyama Japan 16 402 0.6× 280 1.2× 152 0.9× 67 0.5× 92 0.7× 21 855
Sandra van Wilpe Netherlands 12 611 0.9× 135 0.6× 364 2.1× 137 1.0× 40 0.3× 25 1.2k
Lam Leduy Canada 20 699 1.0× 123 0.5× 209 1.2× 94 0.7× 41 0.3× 29 1.0k
Karen E. Hunter United States 7 576 0.8× 404 1.7× 520 3.0× 312 2.2× 66 0.5× 8 1.3k
Sergei F. Barbashov United States 7 380 0.5× 289 1.2× 86 0.5× 40 0.3× 119 1.0× 12 689
D. Mohanraj United States 15 541 0.8× 168 0.7× 181 1.1× 106 0.8× 36 0.3× 43 987

Countries citing papers authored by Astrid Clarke

Since Specialization
Citations

This map shows the geographic impact of Astrid Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Astrid Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Astrid Clarke more than expected).

Fields of papers citing papers by Astrid Clarke

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Astrid Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Astrid Clarke. The network helps show where Astrid Clarke may publish in the future.

Co-authorship network of co-authors of Astrid Clarke

This figure shows the co-authorship network connecting the top 25 collaborators of Astrid Clarke. A scholar is included among the top collaborators of Astrid Clarke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Astrid Clarke. Astrid Clarke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Hamblett, Kevin J., Roma Yumul, Yufei Chen, et al.. (2023). Abstract C132: SGN-35T: A novel CD30-directed antibody-drug conjugate for the treatment of lymphomas. Molecular Cancer Therapeutics. 22(12_Supplement). C132–C132. 2 indexed citations
3.
Shows, Donna, et al.. (2023). T Cell Repertoire Homogeneity and Blood-Gut Overlap in Patients With Inflammatory Bowel Disease. Cellular and Molecular Gastroenterology and Hepatology. 17(1). 119–130. 4 indexed citations
4.
Shows, Donna, et al.. (2023). Janus Kinase Inhibitors Differentially Inhibit Specific Cytokine Signals in the Mesenteric Lymph Node Cells of Inflammatory Bowel Disease Patients. Journal of Crohn s and Colitis. 18(4). 628–637. 6 indexed citations
5.
Hamblett, Kevin J., Julia H. Cochran, Roma Yumul, et al.. (2023). SGN-35C: A Novel CD30-Directed Antibody-Drug Conjugate for the Treatment of Lymphomas. Blood. 142(Supplement 1). 1440–1440. 3 indexed citations
6.
Pohlmeyer, Christopher W., Ching Shang, Zhi-Hua Cui, et al.. (2021). Characterization of the mechanism of action of lanraplenib, a novel spleen tyrosine kinase inhibitor, in models of lupus nephritis. BMC Rheumatology. 5(1). 15–15. 10 indexed citations
7.
Clarke, Astrid, et al.. (2020). P460 Evaluation of potential mechanisms underlying the safety observations of filgotinib in clinical studies in rheumatoid arthritis. Journal of Crohn s and Colitis. 14(Supplement_1). S409–S409.
8.
Kim, Ekaterina, Elisa ten Hacken, Mariela Sivina, et al.. (2019). The BET inhibitor GS-5829 targets chronic lymphocytic leukemia cells and their supportive microenvironment. Leukemia. 34(6). 1588–1598. 19 indexed citations
9.
Clarke, Astrid, Emma Rousseau, Kelly Wang, et al.. (2018). Effects of GS-9876, a novel spleen tyrosine kinase inhibitor, on platelet function and systemic hemostasis. Thrombosis Research. 170. 109–118. 10 indexed citations
10.
Bates, Jamie, Saritha Kusam, Stacey Tannheimer, et al.. (2016). Combination of the BET Inhibitor GS-5829 and a BCL2 Inhibitor Resulted in Broader Activity in DLBCL and MCL Cell Lines. Blood. 128(22). 5104–5104. 2 indexed citations
11.
12.
13.
14.
Clarke, Astrid, Eva Samal, & Lorraine Pillus. (2006). Distinct Roles for the Essential MYST Family HAT Esa1p in Transcriptional Silencing. Molecular Biology of the Cell. 17(4). 1744–1757. 44 indexed citations
15.
Clarke, Astrid, et al.. (2005). POLO Kinase Regulates the Drosophila Centromere Cohesion Protein MEI-S332. Developmental Cell. 8(1). 53–64. 58 indexed citations
16.
Clarke, Astrid, et al.. (2000). Managing the psychological aspects of altered appearance: the impact of disfigurement in visible eye conditions.. UCL Discovery (University College London). 1 indexed citations
17.
Clarke, Astrid, Margaret Lotz, Celia Chao, & Arthur M. Mercurio. (1995). Activation of the p21 Pathway of Growth Arrest and Apoptosis by the β4 Integrin Cytoplasmic Domain. Journal of Biological Chemistry. 270(39). 22673–22676. 115 indexed citations
18.
Clarke, Astrid, Margaret Lotz, & Arthur M. Mercurio. (1994). A Novel Structural Variant of the Human β4 Integrin cDNA. Cell adhesion and communications/Cell adhesion and communication/Cell adhesion & communication. 2(1). 1–6. 32 indexed citations
19.
Lotz, Margaret, et al.. (1993). Decreased expression of Mac-2 (carbohydrate binding protein 35) and loss of its nuclear localization are associated with the neoplastic progression of colon carcinoma.. Proceedings of the National Academy of Sciences. 90(8). 3466–3470. 198 indexed citations
20.
Breen, Elizabeth, Astrid Clarke, Glenn Steele, & Arthur M. Mercurio. (1993). Poorly Differentiated Colon Carcinoma Cell Lines Deficient in α-Catenin Expression Express High Levels of Surface E-cadherin but Lack Ca2+-Dependent Cell-Cell Adhesion. Cell adhesion and communications/Cell adhesion and communication/Cell adhesion & communication. 1(3). 239–250. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tove Irene Klokk Breakdown of academic impact, for papers by Sylvia Braselmann Breakdown of academic impact, for papers by Vinay Bhaskar Breakdown of academic impact, for papers by Rajiv D. Kalraiya Breakdown of academic impact, for papers by Keisuke Aoyama Breakdown of academic impact, for papers by Sandra van Wilpe Breakdown of academic impact, for papers by Lam Leduy Breakdown of academic impact, for papers by Karen E. Hunter Breakdown of academic impact, for papers by Sergei F. Barbashov Breakdown of academic impact, for papers by D. Mohanraj
Rankless by CCL
2026